Showing 4371-4380 of 10629 results for "".
Bringing Cancer Care Home: How Subcutaneous Immunotherapy Can Help Ease the Burden
https://reachmd.com/programs/project-oncology/bringing-cancer-care-home-how-subcutaneous-immunotherapy-can-help-ease-the-burden/35770/As immunotherapy becomes a cornerstone for treating a growing number of solid tumors, reducing the logistical burden of in-office care is essential. Fortunately, the at-home administration of subcutaneous formulations of immunotherapy agents like atezolizumab could help transform the way we care forMS Management: Strategies for Ensuring Equitable Access to Teleneurology
https://reachmd.com/programs/frontlines-multiple-sclerosis/ms-management-strategies-for-ensuring-equitable-access-to-teleneurology/32669/Teleneurology can help provide multidisciplinary care to patients with multiple sclerosis, but key strategies are needed to ensure equitable use.Improving Shingles Vaccination Uptake Through Effective Patient Counseling
https://reachmd.com/programs/vaccination/shingles-vaccination-uptake-patient-counseling/54089/Shingles prevention remains underutilized despite its significant burden in adults aged 50 and older, making effective patient counseling essential in routine care. Given this importance, Dr. Teena Chopra joins Dr. Alexandria May to share practical communication strategies for normalizing shingles vReal-World Impact of Evolocumab on MACE Reduction in ASCVD
https://reachmd.com/clinical-practice/cardiology/real-world-impact-of-evolocumab-on-mace-reduction-in-ascvd/39991/Review real-world data on evolocumab and its association with reduced MACE in patients with established atherosclerotic cardiovascular disease.Targeting Inflammation to Improve Gene Therapy Outcomes in Sickle Cell Disease
https://reachmd.com/programs/clinicians-roundtable/Targeting-Inflammation-to-Improve-Gene-Therapy-Outcomes-in-Sickle-Cell-Disease/35926/Patient Case: ATTRwt-CM Discovered Decades After Heart Transplant
https://reachmd.com/programs/heart-matters/patient-case-attrwt-cm-discovered-decades-after-heart-transplant/32420/Hear about an 88-year-old patient who was unexpectedly diagnosed with wild-type transthyretin cardiac amyloidosis 21 years after a heart transplant.Managing High-Risk Myeloma: From Cytogenetic Abnormalities to Therapeutic Approaches
https://reachmd.com/programs/project-oncology/managing-high-risk-myeloma-from-cytogenetic-abnormalities-to-therapeutic-approaches/26583/Tune in to gain insights into high-risk multiple myeloma, like the genetic factors that play a role in its development as well as treatment options.Insights on the Rising Rates of Syphilis in the United States
https://reachmd.com/programs/clinicians-roundtable/insights-on-the-rising-rates-of-syphilis-in-the-united-states/24153/The United States has seen a 200% increase in congenital syphilis cases in the past five years. Here’s why.The Gene Messenger: Advancing Neurological Gene Therapy
https://reachmd.com/programs/medical-industry-feature/the-gene-messenger-advancing-neurological-gene-therapy/18094/Hear about groundbreaking advances in neurological gene therapy for patients with Parkinson’s disease.Insights on the Benefits of Exercise in Asthma Patients
https://reachmd.com/programs/clinicians-roundtable/insights-on-the-benefits-of-exercise-in-asthma-patients/16290/What challenges do asthma patients face regarding exercise? Find out here.